Chemkart India Peer Comparison

BSE: 544442

₹239.10

₹5.20 (2.22%)

As on 28-Sep-2026IST

Market cap

₹287 Cr

Revenue (TTM)

₹203 Cr

P/E Ratio

14.6

P/B Ratio

2.2

Div. Yield

0 %

Edit

	Chemkart India	Emcure Pharmaceuticals	Wockhardt	Neuland Lab	Piramal Pharma
Market cap (₹ Cr)	287	36,591	35,570	27,470	27,645
Revenue (₹ Cr)	203	9,683	3,564	2,372	9,205
Net Profit (₹ Cr)	24.26	1,018.97	414.00	497.77	-371.81
Net Margin (%)	11.81	10.47	11.23	20.72	-3.93
RoE (%)	58.95	21.30	8.38	28.49	-3.85
Price to Earnings	14.59	36.18	86.97	55.19	--
Price-To-Book	2.21	7.00	7.07	13.59	3.45

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Chemkart India	Emcure Pharmaceuticals	Wockhardt	Neuland Lab	Piramal Pharma
Operating Revenue	203.28	7,896.00	3,012.00	1,476.84	9,151.18
Total Income	205.46	7,968.78	3,074.00	1,497.35	9,312.95
Total Expenditure	170.52	6,427.14	2,619.00	1,153.58	7,733.31
EBITDA	32.76	1,468.85	393.00	323.26	1,417.87
Depreciation	0.53	384.13	217.00	65.55	816.34
EBIT	32.23	1,084.73	176.00	257.71	601.53
Interest	1.82	175.78	254.00	8.30	421.59
Other Income	2.18	72.79	62.00	20.51	161.77
Exceptional Items	--	-10.38	--	76.40	--
Profit before Tax	32.59	971.35	-16.00	346.33	414.64
Provision for Tax	8.33	263.88	41.00	86.22	323.51
Profit after Tax	24.26	707.47	-57.00	260.11	91.13

Liabilities (₹ Cr)

	Chemkart India	Emcure Pharmaceuticals	Wockhardt	Neuland Lab	Piramal Pharma
Shareholder's Funds	53.29	4,446.19	4,353.00	1,524.81	8,125.47
Minority Interest	0.00	195.37	304.00	--	--
Non-Current Liabilities	0.25	811.91	887.00	189.39	3,392.72
Current Liabilities	32.58	2,668.27	2,042.00	465.69	3,850.56
Total Liabilities	86.12	8,121.73	8,100.00	2,179.88	15,513.53

Assets (₹ Cr)

	Chemkart India	Emcure Pharmaceuticals	Wockhardt	Neuland Lab	Piramal Pharma
Non-Current Assets	9.09	3,565.87	5,017.00	1,040.38	9,487.47
Current Assets	77.02	4,555.86	2,465.00	1,139.50	5,881.28
Total Assets	86.12	8,121.73	8,100.00	2,179.88	15,513.53
Total Debt*	17.03	731.70	1,859.00	136.01	4,720.27
Net Current Assets	44.44	1,887.59	423.00	673.81	2,030.72
Contingent Liabilities	0.18	393.94	770.26	8.97	99.76

Cashflow (₹ Cr)

	Chemkart India	Emcure Pharmaceuticals	Wockhardt	Neuland Lab	Piramal Pharma
Cash From Operating Activities	3.97	851.71	-22.00	317.40	892.30
Cash Flow from Investing Activities	-4.25	-94.00	-783.00	-298.16	-477.46
Cash from Financing Activities	3.05	-813.96	409.00	24.96	-440.83
Net Cash Inflow / Outflow	2.77	-56.25	-396.00	44.21	-25.99

Ratios

Profitability Ratios

	Chemkart India	Emcure Pharmaceuticals	Wockhardt	Neuland Lab	Piramal Pharma
ROCE (%)	61.52	22.49	4.07	23.45	6.61
ROE (%)	58.95	19.19	-1.48	18.54	1.14
ROA (%)	34.75	8.94	-0.78	12.97	0.60
EBIT Margin (%)	17.19	19.52	15.11	23.28	17.26
Net Margin (%)	11.81	8.88	-1.85	17.37	0.98
Cash Profit Margin (%)	12.19	13.61	4.14	22.05	8.54

Growth Ratios

	Chemkart India	Emcure Pharmaceuticals	Wockhardt	Neuland Lab	Piramal Pharma
Revenue Growth (%)	53.97	18.59	7.65	-5.24	11.99
EBIT Growth (%)	60.92	19.81	272.95	-27.65	15.16
Net Profit Growth (%)	67.08	34.10	87.92	-13.32	411.39
EPS Growth (%)	67.18	30.75	90.35	-13.32	410.84
Book Value Growth (%)	83.65	50.94	29.77	18.89	2.28

Valuation Ratios

	Chemkart India	Emcure Pharmaceuticals	Wockhardt	Neuland Lab	Piramal Pharma
Price / Earnings	0.00	29.84	0.00	59.57	326.26
Price / Book Value	0.00	4.58	5.31	10.17	3.69
Dividend Yield (%)	--	0.28	0.00	0.10	0.06
EV/EBITDA	0.68	13.55	54.36	44.72	21.49
Market Cap (₹ Cr)	0.00	20,327.45	23,064.69	15,494.53	29,731.27

Solvency Ratios

	Chemkart India	Emcure Pharmaceuticals	Wockhardt	Neuland Lab	Piramal Pharma
Debt to Equity	0.32	0.17	0.43	0.09	0.59
Short term debt to equity ratio	0.32	0.11	0.11	--	0.12
Current Ratio	2.36	1.71	1.21	2.45	1.53
Quick Ratio	1.67	0.98	0.85	1.62	0.93
Interest Coverage	18.92	6.53	0.94	42.74	1.98

Operating Efficiency Ratios

	Chemkart India	Emcure Pharmaceuticals	Wockhardt	Neuland Lab	Piramal Pharma
Debtors to sales (%)	22.53	25.36	21.95	21.38	25.67
Asset Turnover	2.91	1.01	0.53	0.74	0.70
Receivable days	69.50	87.83	60.36	85.17	77.05
Inventory Days	27.20	78.64	64.42	90.97	77.13
Payable days	22.26	174.97	218.94	137.94	173.49
Cash Conversion Cycle	74.43	-8.50	-94.15	38.21	-19.30